← All funding rounds

Llusern raises €58K Seed round

29 March 2023· Cardiff, United Kingdom· health, biotech, b2b, b2g, software_hardware

Investment in a UK-based company developing molecular point-of-care tests for bacterial and viral infections.

Investors

LeadEKF Diagnostics

About Llusern

Stage

Seed

Headquarters

Cardiff, United Kingdom

Founded

2020

Team Size

6–20

Sectors

healthbiotechb2bb2gsoftware_hardware

https://llusern.co.uk/

Source: https://www.ekfdiagnostics.com/res/EKF%20Diagnostics%20Annual%20Report%202022.pdf